GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kangstem Biotech Co Ltd (XKRX:217730) » Definitions » Book Value per Share

Kangstem Biotech Co (XKRX:217730) Book Value per Share : ₩682.89 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Kangstem Biotech Co Book Value per Share?

Kangstem Biotech Co's book value per share for the quarter that ended in Mar. 2025 was ₩682.89.

During the past 12 months, Kangstem Biotech Co's average Book Value Per Share Growth Rate was -13.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -20.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -20.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Kangstem Biotech Co was 30.00% per year. The lowest was -23.50% per year. And the median was -3.70% per year.

Kangstem Biotech Co's current price is ₩1939.00. Its book value per share for the quarter that ended in Mar. 2025 was ₩682.89. Hence, today's PB Ratio of Kangstem Biotech Co is 2.84.

During the past 11 years, the highest P/B Ratio of Kangstem Biotech Co was 16.80. The lowest was 1.54. And the median was 3.16.


Kangstem Biotech Co Book Value per Share Historical Data

The historical data trend for Kangstem Biotech Co's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangstem Biotech Co Book Value per Share Chart

Kangstem Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,573.07 1,557.89 1,129.65 857.70 770.37

Kangstem Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 786.78 918.57 846.66 770.37 682.89

Competitive Comparison of Kangstem Biotech Co's Book Value per Share

For the Biotechnology subindustry, Kangstem Biotech Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kangstem Biotech Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kangstem Biotech Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Kangstem Biotech Co's PB Ratio falls into.


;
;

Kangstem Biotech Co Book Value per Share Calculation

Kangstem Biotech Co's Book Value Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(43,182-0)/56
=770.36

Kangstem Biotech Co's Book Value Per Share for the quarter that ended in Mar. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(38,279-0)/56
=682.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Kangstem Biotech Co  (XKRX:217730) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Kangstem Biotech Co Book Value per Share Related Terms

Thank you for viewing the detailed overview of Kangstem Biotech Co's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Kangstem Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
512 Teheran-ro, Gangnam-gu, 17th Floor, Sinan Building, Seoul, KOR
Kangstem Biotech Co Ltd develops technology to isolate the non-hematological system stem cell with conversion and purity from the cord blood and to culture large quantity. Its Furestem therapies include Furestem-AD, Furestem-RA and Furestem-CD. Its businesses include cord blood-derived stem cell therapy business; cord blood-derived stem cell conditioned media business; and stem cell culture media business.

Kangstem Biotech Co Headlines

No Headlines